Highest-materiality recent filing
NextPlat Q1 revenue $9.9M, gross margin record 35%, net loss narrows 42% YoY
Revenue $9.9M (down 29% YoY); consolidated gross margin record 35% vs 21% prior year.
NextPlat pre-announces Q1 2026: gross margin >34%, expects positive operating income in Q3
Consolidated gross margin expected to exceed 34% in Q1 2026, up from ~20% in FY2025.
NextPlat regains Nasdaq minimum bid price compliance; listing preserved
Received Nasdaq compliance letter on April 27, 2026, confirming bid price rule is met.
NextPlat reports FY2025 revenue $54.3M, net loss $0.44/share; cost cuts of $2M+
Revenue $54.3M, down 18% YoY; healthcare revenue fell to $39.7M, e-commerce rose to $14.6M.
NextPlat approves 1-for-10 reverse stock split to regain Nasdaq bid price compliance
Stockholders approved reverse split at special meeting on March 27, 2026.
NextPlat Q3 revenue $13.8M, net loss narrows 48% YoY; sees Q4 improvement
Revenue $13.8M down from $15.4M YoY; gross margin 19.9% vs 23.2%.
NextPlat granted second 180-day Nasdaq extension; must meet $1 bid by April 27, 2026
Received Nasdaq extension to April 27, 2026 to regain minimum $1.00 closing bid price for 10 consecutive days.
NextPlat appoints Amanda Ferrio as CFO; Cecile Munnik steps down
Cecile Munnik stepped down as CFO on Oct 13, 2025; will remain through Q3 2025 filing.
NextPlat CEO salary raised to $450K; receives 200K fully vested shares
CEO David Phipps annual base salary increased to $450,000 effective September 24, 2025.
NextPlat appoints permanent Chairman and CEO; reports business refocusing progress
Rodney Barreto appointed permanent Chairman; David Phipps permanent CEO, succeeding interim roles after May CEO death.
NextPlat Q2 revenue falls 22% to $13.2M; net loss narrows 66% to $1.8M
Revenue of $13.2M, down from $17.0M YoY; Healthcare Operations revenue declined $4.3M.
NextPlat Corp CEO Charles M. Fernandez passes away; David Phipps named Interim CEO
Executive Chairman and CEO Charles M. Fernandez died on May 24, 2025.
NextPlat CEO Charles M. Fernandez passes away; interim successors named
Charles M. Fernandez, Executive Chairman and CEO since July 2021, died suddenly on May 24, 2025.
NextPlat Q1 revenue down to $14.5M, net loss improves; tariffs pause China product launch
Revenue of $14.5M, down 17% YoY from $17.5M; Healthcare segment declined due to 340B program changes.
NextPlat receives Nasdaq bid price deficiency notice; compliance period through Oct 27, 2025
Common stock closing bid price below $1.00 for 30 consecutive business days triggered Nasdaq deficiency notice on April 28, 2025.
NextPlat to pause US-produced e-commerce in China due to tariff escalation
US/China tariffs will materially and adversely impact NextPlat's business, financial condition, and ability to be profitable.
NextPlat FY2024 revenue $65.5M (+73% YoY); net loss widens to $14.0M
Revenue $65.5M in FY2024 (+73% YoY) driven by full-year Healthcare Operations; net loss $14.0M ($0.68/diluted share) vs $3.8M loss ($0.22) in FY2023.
NextPlat approves $2M buyback; expects record 2024 revenue >$63M (70%+ YoY growth)
Board approved up to $2M share repurchase program; runs through Dec 16, 2025, unless extended.
NextPlat Q3 2024 net loss $4.2M vs prior-year income; 9-month revenue $49.8M (+136%)
Net loss attributable to common shareholders $4.2M ($0.22/sh) in Q3 2024 vs net income $3.4M ($0.17/sh) in Q3 2023.
NextPlat shareholders approve merger with Progressive Care; closing expected Oct 1, 2024
Business combination approved by NextPlat and Progressive Care shareholders at September 13 meetings.
NextPlat Q2 revenues surge 474% to $17M; expects $70M FY2024 revenue
Consolidated Q2 revenue $17.0M (vs $3.0M YoY); gross margin record 34.2% (up from 28.5%).
NextPlat reports record Q1 revenue of $17.5M, up 508% YoY; net loss widens to $1.5M
Consolidated Q1 revenue $17.5M vs $2.9M a year ago; gross margin improved to 27.5% from 21.6%.
Special committees of both boards approved; merger expected to close Q3 2024 subject to shareholder and regulatory approvals.
NextPlat reports FY2023 revenue $37.8M (+222% YoY); net loss narrows to $3.8M
Consolidated revenue $37.8M (+222% YoY); gross margin improved to 30% from 21%.
Total purchase price $760K all-cash; $660K at closing, $100K upon delivery of audited FY2022/23 statements.
NextPlat reports Q3 2023 revenue $15.3M (up 481%), net income $2.6M vs loss last year
Consolidated revenue $15.3M, up 481% YoY vs $2.6M; healthcare ops contributed $12.4M.
Agreement covers nutraceutical and veterinary products from OPKO Europe.
NextPlat exercised cashless warrants for 402,269 shares and cash warrants for 230,000 shares ($506,000 paid).
NextPlat Q2 2023 revenue $3.0M, net loss $4.3M; consolidates Progressive Care
Q2 2023 revenue $3.0M vs $2.9M YoY; gross margin rose to 28.5% from 19.8%.
NextPlat invests $1M in Progressive Care units, converts $2.89M debt for 38.4% stake
NextPlat purchased 455,000 units of Progressive Care at $2.20/unit for $1M; each unit includes one share and one warrant exercisable at $2.20.
NextPlat announces $6.0M private placement of common stock at $1.75/share
Gross proceeds of $6.0M from sale of 3,428,571 shares at $1.75/share, the April 4, 2023 closing price.
NextPlat completes $8.0M private placement of common stock and warrants at $1.75/unit
Closed 4,575,429 units at $1.75/unit: each unit has one share and one warrant (exercise $1.75, 3-year term).
the Company’s Board of Directors (the “Board”) appointed David Phipps, the Company's current President and CEO of Global Operations and Director, as Interim Chief Executive Officer.
As a result of the passing of Charles M. Fernandez, Executive Chairman and Chief Executive Officer of NextPlat Corp (the “Company”), on May 24, 2025
On April 24, 2025, Jervis Hough notified the Company of his immediate resignation as a director of the Company to pursue other interests.
The Board of Directors (the "Board") of NextPlat Corp (the "Company") unanimously elected Ms. Elizabeth Alcaine to the Board to fill a vacancy in the Board effective as of October 1, 2024
On June 9, 2023, in connection with the resignation of Theresa Carlise as NextPlat Corp’s (the “Company”) Chief Accounting Officer, Secretary and Treasurer, the Company entered into a Separation and Mutual Release of Claims Agreement (the “Separation Agreement”) with Ms. Carlise.
on November 2, 2022, the Company’s Board of Directors unanimously elected Robert Bedwell as its Chief Compliance Officer and Cecile Munnik, CPA/CA, as its Chief Financial Officer.
On November 14, 2022, in connection with her appointment as Chief Financial Officer, Ms. Munnik entered into an Employment Agreement with the Company
On September 19, 2022, NextPlat Corp (the "Company") filed with the Securities and Exchange Commission a Current Report on Form 8-K (the "Original Form 8-K") disclosing, among other things, that the Board of Directors of the Company (the "Board") had appointed Ms. Cristina Fernandez to fill a newly-created position on the Board.
On September 13, 2022, the Board of Directors (the “Board”) of NextPlat Corp (the “Company”) unanimously voted to increase the size of the Board from eight to nine directors, and to appoint Ms. Cristina Fernandez to fill the newly created Board position.
On August 24, 2021, Douglas S. Ellenoff was appointed to the positions of Chief Business Development Strategist of Orbsat Corp (the “Company”) and Vice Chairman of the Board of Directors of the Company.
On January 7, 2022, the Board of Directors (the “Board”) of Orbsat Corp (the “Company”) appointed Rodney Barreto as a new director to the Board, effective January 20, 2022.
On January 7, 2022, the Board of Directors (the “Board”) of Orbsat Corp (the “Company”) appointed Rodney Barreto as a new director to the Board, effective January 20, 2022.
Max materiality 0.90 · Median 0.60 · Most common event other_material